Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis.

Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA Jr, Koeffler HP, Thadhani R.

Clin Infect Dis. 2009 Feb 15;48(4):418-24. doi: 10.1086/596314.

PMID:
19133797
2.

Understanding the high infectious disease mortality among patients receiving hemodialysis: Potential risk of concurrently low cathelicidin and gelsolin levels.

DiNubile MJ.

Clin Infect Dis. 2009 Jul 1;49(1):163-4; author reply 164-5. doi: 10.1086/599617. No abstract available.

PMID:
19500030
3.

Vitamin D deficiency and associated factors in hemodialysis patients.

Jean G, Charra B, Chazot C.

J Ren Nutr. 2008 Sep;18(5):395-9. doi: 10.1053/j.jrn.2008.04.003.

PMID:
18721733
4.

Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patients.

Leaf DE, Croy HE, Abrahams SJ, Raed A, Waikar SS.

Crit Care. 2015 Mar 10;19:80. doi: 10.1186/s13054-015-0812-1.

5.

Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis.

St Peter WL, Li S, Liu J, Gilbertson DT, Arneson TJ, Collins AJ.

Pharmacotherapy. 2009 Feb;29(2):154-64. doi: 10.1592/phco.29.2.154.

PMID:
19170585
6.

Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.

Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W.

Arch Intern Med. 2008 Jun 23;168(12):1340-9. doi: 10.1001/archinte.168.12.1340.

PMID:
18574092
7.

Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults.

Dixon BM, Barker T, McKinnon T, Cuomo J, Frei B, Borregaard N, Gombart AF.

BMC Res Notes. 2012 Oct 24;5:575. doi: 10.1186/1756-0500-5-575.

8.

Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis.

Hocher B, Ziebig R, Altermann C, Krause R, Asmus G, Richter CM, Slowinski T, Sinha P, Neumayer HH.

J Am Soc Nephrol. 2003 Sep;14(9):2329-37.

9.

Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease.

Inaguma D, Nagaya H, Hara K, Tatematsu M, Shinjo H, Suzuki S, Mishima T, Kurata K.

Clin Exp Nephrol. 2008 Apr;12(2):126-31. doi: 10.1007/s10157-007-0023-4. Epub 2008 Jan 9.

PMID:
18180871
11.

Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD.

Al-Aly Z, Qazi RA, González EA, Zeringue A, Martin KJ.

Am J Kidney Dis. 2007 Jul;50(1):59-68.

PMID:
17591525
12.

Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients.

Pecovnik-Balon B, Jakopin E, Bevc S, Knehtl M, Gorenjak M.

Ther Apher Dial. 2009 Aug;13(4):268-72. doi: 10.1111/j.1744-9987.2009.00722.x.

PMID:
19695057
13.

A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.

Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL.

J Natl Cancer Inst. 2007 Jul 18;99(14):1120-9. Epub 2007 Jul 10.

PMID:
17623801
14.

Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?

Lomonte C, Antonelli M, Vernaglione L, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Basile C.

J Nephrol. 2005 Jan-Feb;18(1):96-101.

PMID:
15772930
16.

Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.

Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR.

Hemodial Int. 2007 Jul;11(3):315-21.

PMID:
17576296
17.

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.

Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):783-8.

18.

Activated injectable vitamin D and hemodialysis survival: a historical cohort study.

Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA Jr, Thadhani R.

J Am Soc Nephrol. 2005 Apr;16(4):1115-25. Epub 2005 Feb 23.

19.

Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.

Heinz J, Kropf S, Luley C, Dierkes J.

Am J Kidney Dis. 2009 Sep;54(3):478-89. doi: 10.1053/j.ajkd.2009.01.266. Epub 2009 Apr 8.

PMID:
19359080
20.

Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients.

Deicher R, Ziai F, Bieglmayer C, Schillinger M, Hörl WH.

J Am Soc Nephrol. 2005 Jun;16(6):1811-8. Epub 2005 Apr 6.

Supplemental Content

Support Center